Introduction
Diaschisis is an oft-forgotten neurological phenomenon. Introduced in 1914 by von Monakow, the term diaschisis denotes a loss or change of function in regions of the brain remote from the underlying structural (often discrete) lesion due to neuronal connectivity (1) . With the trillions of connections in the human brain (2) , diaschisis is a complex entity that is largely unexplored, and conventional structural imaging with computer tomography (CT) and magnetic resonance imaging are inadequate. In a recent review, Carrera et al. suggested four sub-classifications of diaschisis (3) , that may be more appropriate for mechanistic imaging. Positron emission tomography/computed tomography (PET/CT) with 18F-fluoro-deoxyglucose (FDG) has shown promising results of visual image assessment of diaschisis (4) (5) (6) (7) (8) (9) . Gliomas infiltrate brain parenchyma and destroy healthy brain tissue, which lesions in turn damages other elements of the connectome as manifested by diaschisis.
Here, we test a novel method for detection and quantification of diaschisis with 18F-FDG images from PET/CT in patients with gliomas, and we assessed the prognostic value of the presence of diaschisis.
Material and methods
18F FDG images of the brain were obtained with PET/CT in 14 patients (5 men, 9 women; mean age 63 years, range 35-77) who were admitted to the Department of Neurosurgery, Odense University Hospital, with suspicion of cerebral malignancy. Diagnosis based on biopsy and magnetic resonance imaging showed that two patients had diffuse astrocytoma and 12 had glioblastoma. The patients were followed throughout their treatment course for one year, or until death. The FDG images were acquired prospectively at up to six time-points: 1) before treatment 2) after resection or biopsy, 3) after radiotherapy and/or chemotherapy or no treatment, and 4-6) during chemotherapy or no treatment. Prednisolone was used during the entire treatment course of the glioma patients.
Baseline demographic and clinical characteristics of the study population are detailed in Supplementary Table 1 . For radiotherapy, either 34Gy/ 10 fractions or 59.4/33 fractions were used.
Temozolomide was the standard chemotherapy. The baseline scan was performed a mean of 9 days (range 3-13) after the baseline magnetic resonance images. Follow-up scans were obtained 35 days (range , 121 days (range: 56 -263), 339 days (range: 278 -396), and 466 days (range 368 -536) after the diagnostic magnetic resonance imaging. Tumor volumes were obtained based on volume segmentation of Gadolinium-enhanced T1-weighted images using 3D Slicer Software, The control group consisted of 10 healthy volunteers (5 men, 5 women; mean age 62.5 years, range 43-75) without neurological disease, severe brain trauma, addiction, or cognitive deficits. These control subjects had a single PET/CT session with the same acquisition protocol as for the patients.
All participants gave informed written consent to participate in the study, which was approved by the regional research ethics committee .
PET/CT data acquisition
Participants fasted for six hours before undergoing the imaging. They rested supine on the tomograph bed in a darkened and quiet room, with heads immobilized in a dedicated headrest.
Participants rested for 10 minutes before the tracer was injected at a dose of 200 MBq 18F-FDG for patients and 4 MBq/kg body weight for control subjects. The images were obtained with the Generel Electrics Company Discovery 690 PET/CT device with a dynamic acquisition protocol of 60 one-minute frames. Each frame had 47 slices (3.3 mm) and a display field of view of 250x250 mm (matrix 256x256 pixels). A CT-derived attenuation map was applied, and the data were iteratively reconstructed using time-of-flight ordered subset expectation maximizations. The data from 45-60 minutes were summed and used for analysis. Images were quantified as standardized uptake values (SUV), calculated as radioactivity concentration per gram of tissue in predefined volumes of interest relative to injected dose per kg body weight.
PET image analysis Segmentation
We placed 3D masks around the cerebral and cerebellar hemispheres, both ipsilateral and contralateral to the tumour, using the dedicated software ROVER (ABX, Radeberg, Germany) to segment the volumes of interest. We performed manual correction when a mask clearly included elements outside the brain parenchyma, e.g. parts of the skull or the optic nerve.
We first tested three different cut-off thresholds for the detection of diaschisis: i) a "top-down" procedure with a threshold of either 2 SUVs (2T) or 3 SUVs (3T) below the maximum SUV of the cerebellum or cerebrum, respectively (thus representing the brain parenchyma and neurons with the highest level of FDG accumulation, i.e., the index of functionality), ii) a 40% iterative thresholding algorithm, with either local or global voxel analysis, and iii) a "bottom-up" procedure with a threshold of 0.5 SUV, 2.0 SUV, 3.5 SUV, 4 SUV, or 50% below the maximum SUV. We compared the three methods with respect to THGr and visual assessment of diaschisis, and also tested the level of statistical significance using Kruskal-Wallis equality-of-populations rank test. The "topdown" 3T and 2T approach was found to be most appropriate for quantifying diaschisis in the cerebrum and cerebellum, and included ROVER's built-in partial volume correction feature (11) .
Individual baseline masks were reused on follow-up PET-scans with the software's fixed coregistration procedure. This co-registration procedure was compared against individual placement of the masks.
Inter-hemispheric glucose metabolism
Image quantification with volumetric (3D) segmentation of malignant tissue is referred to as "total lesion glycolysis" (12) , as first introduced by Larson et al. (13) . However, gliomas are known to infiltrate healthy brain tissue and potentially induce regional diaschisis, and we previously observed depressed glucose metabolism in the entire ipsilateral cerebral hemisphere and contralateral cerebellar hemisphere in glioma patients. We thus included non-malignant tissue in the volume of interest and delineated the entire cerebral hemisphere. We refer to the 18F-FDG accumulation in the segmented volumes of interest as "total hemispheric glucose metabolism rate" indices (THG), that are the products of the segmented metabolic volume and the mean SUV in the volume. THG is thus a metabolically segmented parameter, including both malignant and non-malignant tissue, and both white and grey matter.
The hemispheres of likely diaschisis, i.e., the ipsilateral cerebral hemisphere of the supra-tentorial tumour and the contralateral cerebellar hemisphere, were normalized to the respective contralateral hemispheres, providing THG ratio indices (THGr) for cerebrum, THGr(Ce), and cerebellum, THGr(Cb). For assessment of cerebro-cerebellar diaschisis, we constructed a combined THGr index, with cut-off points provided from the area under the curve (AUC) of the ROC analyses of THGr(Ce) and THGr(Cb).
Visual analysis of PET images
The PET images were visually assessed by a nuclear medicine physician experienced in neuroimaging (PG) and blinded to the clinical outcome and the result of the quantitative analysis.
Each FDG image was assessed using the following scale. Cerebrum: 0 = normal (symmetric), 1 = probably normal, 2 = unsure, 3 = probably diaschisis (hypometabolism in two lobes in the same hemisphere), 4 = diaschisis (hypometabolism in three lobes), 5 = severe diaschisis (hypometabolism in four lobes). Cerebellum: 0 = normal (symmetric), 1 = probably normal, 2 = unsure, 3 = probably diaschisis, 4 = diaschisis.
Statistical analysis
Survival time was calculated from the day of surgery. The Kruskal-Wallis test was used to identify statistically significant differences of THGr(Ce) and THGr(Cb) between the participant groups.
ROC analysis was used to investigate THGr as possible predictor of survival less than one year.
AUC of ROC was estimated and the optimal threshold for maximizing classification was found by using the point on the ROC curve closest to the (0,1) corner of the ROC graph (14) . The optimized ROC thresholds for both cerebrum and cerebellum were applied in a 4x4 table, and the value from each set of PET images was plotted below or above the corresponding threshold. The inter-observer variability of two readers for the quantitative analysis was investigated using the coefficient of variation, i.e. the standard deviation divided by the average of values obtained by the three observers. STATA/IC 13.1 (StataCorp, College Station, Texas 77845 USA) was used for all statistical analyses.
Results
In total, 50 18F-FDG image sets were collected prospectively from the 14 patients. Two patients with low-grade glioma (diffuse astrocytoma) were alive at 3 years, whereas median survival for the 12 patients with glioblastoma was 9 months. Baseline clinical characteristics of the glioma cohort are provided in Supplemental Table 1 . Calculation of cerebro-cerebellar diaschisis as THGr was straightforward. Figure 1 shows cerebro-cerebellar diaschisis associated with a glioblastoma, i.e., diaschises in the ipsilateral cerebral hemisphere (THGr <0.62) and the contralateral cerebellar hemisphere (THGr <0.84).
Cerebral diaschisis
Supplemental Table 2 shows the THGr values and results of qualitative diaschisis assessment in the cerebrumfor each patient over time. 
Cerebellar diaschisis
Supplemental Table 3 However, one patient (ID 7) had consecutive cerebellar diaschisis ipsilateral to the glioblastoma, which was located in the occipital lobe above the cerebellar tentorium. As we wanted to calculate the impact of diaschisis using the diaschitic hemisphere as reference point, we switched the cerebellar hemisphere of indexation for this patient.
Comparison of THGr quantification and qualitative assessment
On visual examination, we detected cerebral diaschisis in 78% (39/50) of patient scans, and cerebellar diaschisis in 68% (34/50) ( Table 1 and 2). Cerebro-cerebellar diaschisis was seen in all of the 32 PET scans of glioblastomas perfomed less than one year before death and in 42% (5/12) of the 18F-FDG-PET scans performed more than one year before death (including low-grade gliomas).
Cerebral diaschisis was seen in 94% (16/17) of cases where cerebral THGr was low (i.e. less than 0.61), and cerebellar diaschisis was seen in 96% (25/26) of cases where cerebellar THGr was low (i.e. less than 0.84).
Prediction by combining THGr for forebrain and hindbrian
For initial differentiation between "glioma brain" and "healthy brain", ROC analysis revealed optimal thresholds of THGr(Ce) at 0.91 and THGr (Cb) at 0.79. THGr estimates below these thresholds in both cerebrum and cerebellum gave 100% sensitivity and 41% specificity of differentiating a patient with glioma from a healthy volunteer.
For prognosis of survival for more than one year after the 18F-FDG-PET scan, in glioblastoma patients, the AUC of ROC revealed thresholds of THGr(Ce) at 0.62 and THGr(Cb) at 0.84. When neither THGr(Ce) and THGr(Cb) value reached the threshold, the combined diaschisis measures had 100% positive predictive value. When only one value failed to reach the threshold, the measure had 75% positive predictive value, and when both test values exceeded the thresholds, the measures had 79% negative predictive value for survival below or above one year for the glioblastoma patients. A positive combined diaschisis test provided 88% sensitivity and 73% specificity for survival below or above one year after the PET imaging. Table 1 list the results of the AUC of ROC thresholds used in the "combined diaschisis" test.
Inter-observer variability and co-registration follow-up images
The median coefficient of variation for estimates by two independent observers were 3.3% for THGr(Ce) (interquartile range 1.9%-4.2%) and 5.9% for THGR(Cb) (Interquartile range 3.3%-14%) ( Supplemental Figure 2) . We found the automated reuse of the baseline 3D masks to the patients to be a robust and practical method for segmentation. Taking all time-points together, the mean Table 4 ). We also compared reuse of baseline masks stratified to any specific treatment intervention, i.e., post-operation or post chemotherapy; no statistical significant difference was found either (p-value range 0.055-0.96). Automated reuse of the 3D masks allowed excellent delineation of the cerebral and cerebellar structures for visual assessment.
Discussion
The study results showed that estimation of total hemispheric glucose metabolic ratio (THGr) was straightforward and meaningfully could quantify diaschisis in the cerebrum and cerebellum of patients with glioma. Quantitative and visual detection of diaschisis was associated with shorter survival. THGr estimates had low inter-observer variability despite differences of patient treatments with neurosurgery, radiotherapy, and chemotherapy.
Diaschisis in patients with glioblastoma
Mean age (63 years) and median survival (9 months) for the glioblastoma patients, were similar to those reported in the literature (63.7 years and 9.9 months)(15). Glioblastoma patients who survived less than one year had low THGr in most of their cerebral and cerebellar images. Glioblastoma patients surviving for more than one year had a few images with THGr below ROC threshold, but not at the same time in both in cerebrum and cerebellum. The presence of cerebro-cerebellar diaschisis detected with the combined diaschisis test thus had 100% positive predictive value of survival for less than one year. Our findings suggest that an unusually high THGr value may also indicate severe disease (e.g. widespread invasive disease and very short survival), but this is based on only two patients with high values. Note that both these patients either had a biopsy performed (Pt 6) or a partial removal (Pt4); the neurosurgical intervention might be interesting to elaborate further with THGr in patients with glioma and the correlation to diaschisis.
Low-grade gliomas
The two patients with low-grade glioma did not display any significant cerebro-cerebellar diaschisis during the follow-up. Although one-third of the nine images had low cerebral THGr, the cerebrocerebellar pathways probably were not significantly affected by the neoplasms, as the cerebellar THGr values exceeded the ROC thresholds. The patient with the lowest cerebral THGr values had chronic hearing loss originating in the ipsilateral hemisphere after resection, as well as aggressive Jackson epileptic seizures, and this was the only patient with low-grade glioma who experienced cancer recurrence. In the light of the THGr results presented for low grade gliomas, one hypothesis is that if a low grade glioma presents with a positive "combined diaschisis" test, this might indicate progression to glioblastoma/ progressive damage to the neuronal connections.
Strengths and weaknesses
This method of quantifying diaschisis improves the understanding of some poorly understood pathophysiological mechanisms in the brain, which may help to improve management strategies for patients with glioma.The study had a small sample size,was exploratory in nature, and time between scans and treatment was heterogeneous. Hence, confounding factors such as age, sex, and treatment intervention was not suitable for a multivariate analysis. However, we systematically and prospectively collected 50 FDG images during the course of treatment of patients for glioma that constitutes a unique material in the literature. The longitudinal study design enabled us to investigate the presence of diaschisis at three to six time-points during a time period of between three months and more than a year, of which validated the reproducibility of the method across heterogeneous treatment interventions. The combined estimation of THGr values in the ipsilateral cerebrum and the contralateral cerebellum provided a way of quantifying cerebro-cerebellar diaschisis that would allow comparison of results between institutions, with less interference from misinterpretation of SUV, and differences in tracer dose, device brand, and acquisition times(16).
The method presented here may be relevant also for other brain diseases. FDG imaging has suggested the presence of diaschisis in multiple sclerosis(17), Lyme's disease(18), thalamocortical lesions(5), traumatic diffuse brain injury(19), and dementia(20). Baron and colleagues found that a cerebral hemispheric ratio below 0.85 in thalamocortical lesions consistently was associated with cognitive impairment (5) . Psychological disorders can also display decreased regional or global glucose metabolism, wich can be speculated to also be caused by diaschisis, e.g. chronic fatigue syndrome(21), post-traumatic stress disorder(22), major depressive disorder(23), and chronic depression syndromes(24).
Moreover, diaschisis has been suggested to represent a reversible neurological phenomenon by Sobesky and colleagues(25). They found that "reversal" of diaschisis along the treatment trajectory was associated to better clinical outcome in stroke patients. In this respect, the THGr method 
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postoperative or post-chemotherapy), but no statistically significant difference was found (p values ranged from 0.055 to 0.96). The large mask size and the relatively fixed anatomical shape of the target structures could explain these good results, which indicate that the automated reuse of cerebral hemispheric and cerebellar masks provided in the ROVER software is applicable for routine clinical use.
